INDO US BIOTECH
Back to Balance Sheet
|
INDO US BIOTECH Last 5 Year Deferred Tax Assets / Liabilities History
[Standalone]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹-0.70 Cr | ₹-0.66 Cr | ₹-0.59 Cr | ₹-0.42 Cr | ₹-0.26 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of INDO US BIOTECH ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2025 | ₹-0.70 Cr |
Mar2024 | ₹-0.66 Cr |
Mar2023 | ₹-0.59 Cr |
Mar2022 | ₹-0.42 Cr |
Mar2021 | ₹-0.26 Cr |
How is Deferred Tax Assets / Liabilities of INDO US BIOTECH Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹-0.70 Cr | Negative | |
Mar2024 | ₹-0.66 Cr | Negative | |
Mar2023 | ₹-0.59 Cr | Negative | |
Mar2022 | ₹-0.42 Cr | Negative | |
Mar2021 | ₹-0.26 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of INDO US BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INDO US BIOTECH | ₹247.2 Cr | -5.9% | -13.5% | -52.3% | Stock Analytics | |
BOMBAY BURMAH TRADING CORPORATION | ₹13,951.9 Cr | 5.7% | 2.2% | -29.4% | Stock Analytics | |
KAVERI SEED COMPANY | ₹5,464.9 Cr | -0% | -11.7% | 17.1% | Stock Analytics | |
VENKYS (INDIA) | ₹2,042.1 Cr | -2.1% | -4.2% | -22.5% | Stock Analytics | |
BOMBAY SUPER HYBRID SEEDS | ₹1,277.0 Cr | -1.8% | -7.8% | -28.8% | Stock Analytics | |
MANGALAM GLOBAL ENTERPRISE | ₹498.0 Cr | -9.8% | -4.8% | NA | Stock Analytics |
INDO US BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INDO US BIOTECH | -5.9% |
-13.5% |
-52.3% |
SENSEX | 1.8% |
1.9% |
2.4% |
You may also like the below Video Courses